StreetAlpha.app
Home › Stocks › NVO

Novo Nordisk a S (NVO)

Healthcare
$37.82
▼ −2.70%
LAST CLOSE · NOV 20

Novo Nordisk makes and sells medicines for obesity, diabetes and rare diseases, and is based in Denmark. It last closed at $37.82 on Nov 20, down 2.70% on the day.

AI Auto Pilots
Is NVO in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold NVO.

Key Stats

Fiscal 2025
Results
Revenue
DKK 309B
+6.4% vs a year ago
Net income
DKK 102B
+1.4% vs a year ago
Free cash flow
DKK 59.0B
19.1% margin
Gross margin
81.0%
DKK 250B gross profit
Balance sheet
Cash & equivalents
DKK 26.5B
At Dec 31
Debt
DKK 131B
At Dec 31
Shareholder equity
DKK 194B
Employees69,505 (Dec 31, 2025)
Fiscal year endsDecember
ExchangeNYSE
Financials history
FY2021: DKK 141BDKK 141BFY2021FY2022: DKK 177BDKK 177BFY2022FY2023: DKK 232BDKK 232BFY2023FY2024: DKK 290BDKK 290BFY2024FY2025: DKK 309BDKK 309BFY2025

From NVO's SEC filings, latest 20-F for the period ending Dec 31, 2025 (filed Feb 4). Figures are in DKK. Per share figures are left out because the US listing can represent a different number of shares.

Next report
—
No date on the calendar yet
Consensus EPS forecast
EPS and revenue estimates
Year-ago EPS
Same quarter last year
Options-implied move
Move priced in by options
Analyst consensus
Ratings from the last 90 days
Loading…

Analyst Ratings & Price Targets

Analyst Ratings →
AI Starter and AI Pro
Full analyst coverage on NVO
  • Every upgrade, downgrade and initiation as it happens
  • Every price target change, raised or cut
  • Consensus rating with the average, high and low targets
  • Each firm's full rating history on NVO

Technical Analysis

NVO · as of the Nov 20 close · updated each morning
Downtrend, nearing oversold

The stock is 6% below its 20 day and 5% below its 50 day average. It is 13% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 38), near oversold. The nearest support is the Pivot S1 at $37.34, and the nearest resistance the Pivot at $38.23.

Short trendBearish
Long trendBearish
MomentumWeak
StretchNear oversold
VolatilityHigh, 3.0%/day
Key levels
$64.1652 week high+69.6%
$43.57100 day average+15.2%
$42.88200 day average+13.4%
$40.1320 day average+6.1%
$39.68Swing high (Oct 15)+4.9%
$39.5950 day average+4.7%
$38.71Pivot R1+2.4%
$38.23Pivot+1.1%
$37.82Last close
$37.34Pivot S1−1.3%
$36.84Swing low (Oct 6)−2.6%
$35.1252 week low−7.1%
Indicators
RSI (14)38.01Weak, oversold below 30Neutral
MACD-0.10Below its signal lineBearish
Stochastic3.2Near the bottom of its rangeOversold
ADX (14)16.6No clear trend
Williams %R-98.7Oversold below −80, overbought above −20Oversold
CCI (20)-139.3Oversold below −100, overbought above 100Oversold
Rate of change−6.2%Change over 10 sessionsBearish
ATR (14)$1.13Typical daily range, 3.0% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for NVO

What happened before

See how NVO did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.

November seasonalityHow NVO usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.

Seasonality

How NVO has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2005.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Whale options flow for NVOHow many large options trades hit NVO, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in

See today’s whale options flow across the market →

Dark Pool

30D
Prints
Notional
Largest print
Loading…

NVO Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Neutral
Strongly bearishNeutralStrongly bullish
  • ▼482 buying vs 716 selling
  • ▲Shares held by funds +3.5%
  • ▼Funds holding -120
  • ▲Superinvestors: 5 added, 0 cut
  • ▲Put/call 1.50 to 1.37
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holding
Q3 2026This quarterLast quarterChange
Funds holding1,2401,360−8.8%
In funds' top 10814−42.9%
Held by funds–––
New / increased93 / 389199 / 463−27.2%
Reduced / sold out508 / 208458 / 122+23.4%
Put/call ratio1.371.50−9.0%
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See NVO institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

AI Auto Pilots

Paper trading

StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether NVO is in one of them and how their past NVO trades turned out.

NVO in the AI portfolios
Loading…

NVO News Tone and Price

Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered NVO in an article yet. Here's the latest on the wider market.

NVO in the news

NVO Congress Trades

All congress trades →
Trades, 12 months
4
Buys
2
50%
Sells
2
50%
People
3
Last filed Sep 25
Who traded NVO · since 2015
Latest 5 filings of 43
$1K – $15KTraded Sep 10, 2026Filed Sep 25, 2026
Kevin HernSell (partial)
$1K – $15KTraded Aug 31, 2026Filed Sep 25, 2026
$1K – $15KTraded Aug 26, 2026Filed Sep 17, 2026
$15K – $50KTraded Mar 30, 2026Filed Jul 21, 2026
$1K – $15KTraded Oct 31, 2025Filed Nov 21, 2025
PersonTypeAmountTradedFiledDelay
Kevin HernR · OKSell$1K – $15KSep 10, 2026Sep 25, 202615 d
Kevin HernR · OKSell (partial)$1K – $15KAug 31, 2026Sep 25, 202625 d
Clifford FranklinR · FLBuy$1K – $15KAug 26, 2026Sep 17, 202622 d
Alan ArmstrongR · OKBuy$15K – $50KMar 30, 2026Jul 21, 2026113 d
Lisa McClainR · MISell$1K – $15KOct 31, 2025Nov 21, 202521 d

From official House and Senate disclosure reports, filed up to 45 days after the trade and shown in dollar ranges. Not investment advice. Use limited by 5 U.S.C. 13107. About this data

About Novo Nordisk a S

Novo Nordisk is a healthcare company based in Bagsvaerd, Denmark, that discovers, develops, makes and sells pharmaceutical products. Its main focus is obesity and diabetes care, with products including insulin and medicines for weight management and type 2 diabetes. It also sells treatments for rare diseases, mainly growth hormone and haemophilia products. Its customers include patients, doctors and healthcare systems worldwide.

Headquarters
Bagsvaerd Denmark, Denmark